Granules India opens advanced Centres of Excellence in Hyderabad
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
From material selection to cooling tower management, every small decision affects long-term equipment reliability
AI-powered cardiometabolic wellness platform for India’s workforce
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
Subscribe To Our Newsletter & Stay Updated